Amber Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Urinary incontinence neuromod newcomer Amber Therapeutics nets $100M

The University of Oxford spinout's series A round follows up on positive preliminary data from a first-in-human trial earlier this year.

Tiffany leAidan crawleyOxford science enterprisesUniversity of oxfordEnterprise associatesAmber therapeuticsNew enterprise associatesF prime capitalLightstone venturesIntuitive ventures

Amber Therapeutics announces positive preliminary results from its first-in-human investigation of Amber-UI, its new adaptive implanted pudendal neuromodulation system for urinary incontinence

Amber Therapeutics announces positive preliminary results from its first-in-human investigation of Amber-UI, its new adaptive implanted pudendal neuromodulation system for urinary incontinence
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomPicostim dyneumoAidan crawleySandi greenwoodSociety of urodynamicsOxford science enterprisesUniversity hospital antwerp belgiumUniversity of oxfordProfessor of urology at antwerp universityFemale pelvic medicineUrogenital reconstructionAmber therapeuticsAugmenting urinary reflex activityUniversity hospital antwerpStefan de wachter

Amber Tx acquires Bioinduction Limited and its Picostim DyNeuMo platform, on which Amber s closed-loop neuromodulation therapy for mixed urinary incontinence is being developed

Amber Tx acquires Bioinduction Limited and its Picostim DyNeuMo platform, on which Amber s closed-loop neuromodulation therapy for mixed urinary incontinence is being developed
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomPicostim dyneumoTim denisonAidan crawleyBioinduction limitedUniversity of oxfordOxford science enterprisesAmber therapeuticsFinetech medicalChief engineerInnovate united kingdomBiomedical catalystUrinary incontinenceCurrent neuromodulationFrazer hall